Sulfuric Acid

Sulfuric Acid

SCHEMBL5598588

Cc1ccc[n+](C)c1C.Cc1ccc[n+](C)c1C.O=S(=O)([O-])[O-]

nearest known ligand 0.33

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.33
KMT2A Q03164 3/20 0.33
TDP1 Q9NUW8 3/20 0.33
L3MBTL1 Q9Y468 3/20 0.33
NSD2 O96028 2/20 0.33
POLB P06746 2/20 0.33
MAPT P10636 2/20 0.33
THRB P10828 2/20 0.33
RECQL P46063 2/20 0.33
GALK1 P51570 2/20 0.33
BLM P54132 2/20 0.33
TDP2 O95551 1/20 0.33
USP2 O75604 1/20 0.33
MEN1 O00255 1/20 0.33
PABPC1 P11940 1/20 0.33
RAB9A P51151 1/20 0.33
ALDH1A1 P00352 4/20 0.32
GAA P10253 1/20 0.32
HPGD P15428 1/20 0.32
KLK7 P49862 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfuric Acid SCHEMBL5598595 0.92 USP2 (0.35) KDM4EKMT2ATDP1L3MBTL1NSD2
SCHEMBL11440959 0.89 NPSR1 (0.36) KDM4EKMT2ATDP1L3MBTL1NSD2
Trifluoromethanesulfonic Acid SCHEMBL3635767 0.87 KCNH2 (0.42) ACHE
SCHEMBL2495381 0.87
SCHEMBL29188655 0.86 LMNA (0.44) KDM4EKMT2ATDP1MAPTMEN1
Bromide SCHEMBL30517303 0.84 KMT2A (0.38) KDM4EKMT2ATDP1L3MBTL1NSD2
Hydrochloric Acid SCHEMBL6267344 0.84 KMT2A (0.38) KDM4EKMT2ATDP1L3MBTL1NSD2
Bromide SCHEMBL8748601 0.84 KMT2A (0.38) KDM4EKMT2ATDP1L3MBTL1NSD2
Fluoride Ion SCHEMBL12474470 0.84 KMT2A (0.38) KDM4EKMT2ATDP1L3MBTL1NSD2
Bromide SCHEMBL28737975 0.84 KMT2A (0.38) KDM4EKMT2ATDP1L3MBTL1NSD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4553061-A1 METHOD FOR PRODUCING FLUORINATED ORGANIC COMPOUND DAIKIN INDUSTRIES, LTD. (JP) 2025-05-14 EP disclosed
WO-2024009998-A1 METHOD FOR PRODUCING FLUORINATED ORGANIC COMPOUND ダイキン工業株式会社 2024-01-11 WO disclosed
CN-112020485-B Process for producing difluoromethylene compound 大金工业株式会社 2023-11-14 CN disclosed
EP-4223736-A1 PRODUCTION METHOD FOR FLUORINATED ORGANIC COMPOUND Daikin Industries, Ltd. (JP) 2023-08-09 EP disclosed
US-20230242468-A1 PRODUCTION METHOD FOR FLUORINATED ORGANIC COMPOUND DAIKIN INDUSTRIES, LTD. (JP) 2023-08-03 US disclosed
US-11377407-B2 Method for producing difluoromethylene compound DAIKIN INDUSTRIES, LTD. (JP) 2022-07-05 US disclosed
WO-2022071363-A1 PRODUCTION METHOD FOR FLUORINATED ORGANIC COMPOUND ダイキン工業株式会社 2022-04-07 WO disclosed
US-20210363077-A1 METHOD FOR PRODUCING DIFLUOROMETHYLENE COMPOUND DAIKIN INDUSTRIES, LTD. (JP) 2021-11-25 US disclosed
US-11091432-B2 Composition, fluorinating reagent, and method for producing fluorinated organic compound DAIKIN INDUSTRIES, LTD. (JP) 2021-08-17 US disclosed
CN-107531586-B Composition, fluorinating agent, and method for producing fluorinated organic compound 大金工业株式会社 2021-05-18 CN disclosed
US-7311890-B2 Process for the production of fluorinated organic compounds and fluorinating agents DAIKIN INDUSTRIES, LTD. (JP) 2007-12-25 US disclosed
US-20040245505-A1 Process for the production of fluorinated organic compounds and fluorinating agents DAIKIN INDUSTRIES, LTD. (JP) 2004-12-09 US disclosed
US-6784327-B2 ORGANIC COMPOUNDS HAVING HYDROGEN ATOMS, WHICH SERVE AS STARTING MATERIALS, ARE FLUORINATED USING IF5 DAIKIN INDUSTRIES, LTD. (JP) 2004-08-31 US disclosed
US-20030176747-A1 Process for the production of fluorinated organic compounds and fluorinating agents DAIKIN INDUSTRIES, LTD. (JP) 2003-09-18 US disclosed
CN-1436159-A Processes for production of fluorinated organic compounds and fluorinating agent DAIKIN IND LTD (JP) 2003-08-13 CN disclosed
EP-1304316-A1 PROCESSES FOR THE PRODUCTION OF FLUORINATED ORGANIC COMPOUNDS AND FLUORINATING AGENTS Daikin Industries, Ltd. (JP) 2003-04-23 EP disclosed
EP-0781752-B1 Process for preparing fluorine-containing dicarbonyl compound DAIKIN IND LTD (JP) 2001-02-21 EP disclosed
EP-0781752-A1 Process for preparing fluorine-containing dicarbonyl compound DAIKIN INDUSTRIES, LIMITED (JP) 1997-07-02 EP disclosed
US-5569778-A REACTING DICARBONYL COMPOUND WITH FLUORINE IN HALOGENATED HYDROCARBON OR NITRILE SOLVENT DAIKIN INDUSTRIES LTD. (JP) 1996-10-29 US disclosed
EP-0667332-A1 PROCESS FOR PRODUCING FLUORINATED DICARBONYL COMPOUND DAIKIN INDUSTRIES, LIMITED (JP) 1995-08-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11091432-B2 Composition, fluorinating reagent, and method for producing fluorinated organic compound IPO5, AFF2, IL5 KDM4E 3611/4885KMT2A 3770/4885TDP1 2523/4885
US-20040245505-A1 Process for the production of fluorinated organic compounds and fluorinating agents PFAS, AFF4, AFF1 KDM4E 3812/4885KMT2A 3143/4885TDP1 2061/4885
US-20230242468-A1 PRODUCTION METHOD FOR FLUORINATED ORGANIC COMPOUND IPO5, PFAS, FBL KDM4E 3625/4885KMT2A 3544/4885TDP1 4037/4885
US-20030176747-A1 Process for the production of fluorinated organic compounds and fluorinating agents PFAS, AFF4, AFF1 KDM4E 3812/4885KMT2A 3143/4885TDP1 2061/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.